Aligos Therapeutics Statistics
Total Valuation
ALGS has a market cap or net worth of $47.15 million. The enterprise value is -$82.84 million.
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ALGS has 6.11 million shares outstanding. The number of shares has increased by 84.13% in one year.
Current Share Class | 5.31M |
Shares Outstanding | 6.11M |
Shares Change (YoY) | +84.13% |
Shares Change (QoQ) | +38.64% |
Owned by Insiders (%) | 2.91% |
Owned by Institutions (%) | 32.51% |
Float | 2.94M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 16.05 |
Forward PS | n/a |
PB Ratio | 0.40 |
P/TBV Ratio | 0.40 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.56, with a Debt / Equity ratio of 0.07.
Current Ratio | 7.56 |
Quick Ratio | 7.28 |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -60.44% and return on invested capital (ROIC) is -55.47%.
Return on Equity (ROE) | -60.44% |
Return on Assets (ROA) | -38.74% |
Return on Invested Capital (ROIC) | -55.47% |
Return on Capital Employed (ROCE) | -65.54% |
Revenue Per Employee | $46,714 |
Profits Per Employee | -$760,857 |
Employee Count | 70 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ALGS has paid $350,000 in taxes.
Income Tax | 350,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.53% in the last 52 weeks. The beta is 2.69, so ALGS's price volatility has been higher than the market average.
Beta (5Y) | 2.69 |
52-Week Price Change | -39.53% |
50-Day Moving Average | 5.60 |
200-Day Moving Average | 15.67 |
Relative Strength Index (RSI) | 64.11 |
Average Volume (20 Days) | 141,740 |
Short Selling Information
The latest short interest is 552,791, so 9.04% of the outstanding shares have been sold short.
Short Interest | 552,791 |
Short Previous Month | 640,196 |
Short % of Shares Out | 9.04% |
Short % of Float | 18.79% |
Short Ratio (days to cover) | 3.51 |
Income Statement
In the last 12 months, ALGS had revenue of $3.27 million and -$53.26 million in losses. Loss per share was -$16.86.
Revenue | 3.27M |
Gross Profit | -65.14M |
Operating Income | -86.35M |
Pretax Income | -75.52M |
Net Income | -53.26M |
EBITDA | -85.41M |
EBIT | -86.35M |
Loss Per Share | -$16.86 |
Full Income Statement Balance Sheet
The company has $137.86 million in cash and $7.87 million in debt, giving a net cash position of $129.99 million or $21.26 per share.
Cash & Cash Equivalents | 137.86M |
Total Debt | 7.87M |
Net Cash | 129.99M |
Net Cash Per Share | $21.26 |
Equity (Book Value) | 116.45M |
Book Value Per Share | 19.04 |
Working Capital | 124.26M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$78.91 million and capital expenditures -$104,000, giving a free cash flow of -$79.01 million.
Operating Cash Flow | -78.91M |
Capital Expenditures | -104,000 |
Free Cash Flow | -79.01M |
FCF Per Share | -$12.92 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -2,640.70% |
Pretax Margin | -1,618.04% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ALGS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -84.13% |
Shareholder Yield | -84.13% |
Earnings Yield | -112.97% |
FCF Yield | -167.59% |
Analyst Forecast
The average price target for ALGS is $70.00, which is 807.91% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $70.00 |
Price Target Difference | 807.91% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | 136.18% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on August 19, 2024. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Aug 19, 2024 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
ALGS has an Altman Z-Score of -5.12 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -5.12 |
Piotroski F-Score | 1 |